Wright G E, Gambino J J
J Med Chem. 1984 Feb;27(2):181-5. doi: 10.1021/jm00368a013.
Quantitative structure-activity relationships (QSAR) of a series of 6-anilinouracil derivatives were developed for their inhibitory activity against the wild-type DNA polymerase III (pol III) and a mutant enzyme, pol III/azp-12, derived from Bacillus subtilis. Interaction between inhibitors and both enzymes appears to result solely from hydrophobic binding. Comparison of the substituent contributions indicates increased hydrophobic character and a minor change of shape of the inhibitor binding site of the mutant enzyme. Because the two enzymes have identical Km values for substrates, the inhibitor binding site is thought to be distinct from the enzyme active site.
针对一系列6-苯胺基尿嘧啶衍生物对野生型DNA聚合酶III(pol III)和源自枯草芽孢杆菌的突变酶pol III/azp-12的抑制活性,建立了定量构效关系(QSAR)。抑制剂与这两种酶之间的相互作用似乎仅源于疏水结合。取代基贡献的比较表明,突变酶的抑制剂结合位点的疏水特性增加,形状有微小变化。由于这两种酶对底物的Km值相同,因此认为抑制剂结合位点与酶活性位点不同。